Showing results (421-430 of 624) with videos related to

Sort By:
Pageof 63
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMAF Mandelli, M C Petti, A Ardia, et al.
Leukemia|May 1, 1993
Pilot study of 5-aza-2'-deoxycytidine (Decitabine) in the treatment of poor prognosis acute myelogenous leukemia patients: preliminary resultsM C Petti, F Mandelli, V Zagonel, et al.
British Journal of Haematology|February 19, 2002
Melphalan treatment in patients with myelofibrosis with myeloid metaplasiaM C Petti, R Latagliata, T Spadea, et al.
Acta Haematologica|January 1, 1984
A study of the mechanisms and sites of action of desferrioxamine in thalassaemia majorI Bianco, B Graziani, M Lerone, et al.
American Journal of Nephrology|January 1, 1987
Risk of iron overload and 'hemochromatosis allele(s)' in patients on maintenance hemodialysisM Taccone-Gallucci, G Di Nucci, C Meloni, et al.
Annals of Hematology|April 1, 1992
A randomized study of the efficacy of postconsolidation therapy in adult acute nonlymphocytic leukemia: a report of the Italian Cooperative Group GIMEMAF Mandelli, M L Vegna, G Avvisati, et al.
Bone Marrow Transplantation|May 1, 1990
Interferon therapy for Ph1 positive CML patients relapsing after T cell-depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, G Alimena, et al.
Cancer|November 14, 1997
Langerhans' cell histiocytosis in adults: a clinical and therapeutic analysis of 11 patients from a single institutionF Giona, R Caruso, A M Testi, et al.
The New England Journal of Medicine|May 17, 1990
Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapyF Mandelli, G Avvisati, S Amadori, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspectiveP Mazza, S Tura, M Bocchia, et al.
Pageof 63